Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04413799 · ClinicalTrials.gov registry record · Early Phase 1
PVB vs Ketamine/Lidocaine in Rib Fracture Patients
A Early Phase 1 study, sponsored by George Washington University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
NCT04413799 is a Early Phase 1 study that was terminated before completion, run by George Washington University. The registered enrollment target is 32 participants.
The verdict
NCT04413799, a Early Phase 1 study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
Rib fractures are a common admission to the trauma service. The mainstay of treatment is pain control to improve respiratory effort in order to offset the risk of pneumonia and mechanical ventilation. In addition to standard pain control modalities, the investigator's institution utilizes paravertebral blocks as well as lidocaine and ketamine infusions for pain control. The current standard of care for pain control is to begin with acetaminophen, ibuprofen or celecoxib and opioids with the addition of paravertebral blocks as needed. In certain situations, a paravertebral block is contraindicated, and pain control is relegated to lidocaine and ketamine infusion. The use of lidocaine infusion alone and ketamine infusion alone for pain control has been studied and has been shown to be safe. However, concurrent use of these two medications to control rib fracture pain is relatively new and the efficacy compared to paravertebral block is not known. The goal of the study is to show non-inferiority of simultaneous lidocaine and ketamine infusions versus paravertebral blocks.
Interventions
- COMBINATION_PRODUCT lidocaine, ketamine intravenous infusion
- DRUG paravertebral block with ropivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2025-01-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04413799
The ClinicalTrials.gov registry entry for NCT04413799 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lidocaine, ketamine intravenous infusion is the first listed.
NCT04413799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04413799 about?
NCT04413799 is a clinical study titled "PVB vs Ketamine/Lidocaine in Rib Fracture Patients". Rib fractures are a common admission to the trauma service. The mainstay of treatment is pain control to improve respiratory effort in order to offset the risk of pneumonia and mechanical ventilation. In addition to standard pain control modalities, the investigator's institution utilizes paraverteb...
What is the current status of trial NCT04413799?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2020-09-01. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT04413799?
The interventions under investigation include: lidocaine, ketamine intravenous infusion (COMBINATION_PRODUCT), paravertebral block with ropivicaine (DRUG).
Who is sponsoring clinical trial NCT04413799?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.